You have 9 free searches left this month | for more free features.

City

Ballarat (1)

Box Hill (1)

Geelong (1)

Heidelberg (1)

Madison (1)

Perth (1)

Sendai-shi (1)

Condition

Follicular Lymphoma Stage II (1)

Follicular Lymphoma Stage III (1)

Follicular Lymphoma Stage IV (1)

Healthy Participants (1)

Healthy Volunteer (1)

Relapsed or Refractory T-cell Lymphomas (1)

Overall Status

Not yet recruiting (3)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Bristol-Myers Squibb (3)

Olivia Newton-John Cancer Research Institute (1)

Collaborator

Austin Health (1)

Barwon Health (1)

Bristol-Myers Squibb (1)

Eastern Health (1)

Fiona Stanley Hospital (1)

Grampians Health (1)

Intervention

bms-986369 (4)

nivolumab 10 mg/ml (1)

rituximab (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (3)

Other (1)

Study Type

Interventional (4)

bms-986369

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Relapsed or Refractory T-cell Lymphomas Trial in Sendai-shi (BMS-986369)

Not yet recruiting

Relapsed or Refractory T-cell Lymphomas

BMS-986369

Sendai-shi, Miyagi, Japan

Local Institution - 0001

Sep 12, 2023

Healthy Participants Trial in Madison (BMS-986369)

Recruiting

Healthy Participants

BMS-986369

Madison, Wisconsin

Labcorp Clinical Research Unit - Madison

Nov 27, 2022

Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV Trial in Australia (BMS-986369,

Not yet recruiting

Follicular Lymphoma Stage II
+2 more

BMS-986369
+2 more

Ballarat, Victoria, Australia
+4 more

Mar 15, 2023

Healthy Volunteer Trial (BMS-986369)

Not yet recruiting

Healthy Volunteer

BMS-986369

(no location specified)

Apr 25, 2022